INIZIATIVE BRESCIANE-INBRE S (IB.MI) Fundamental Analysis & Valuation

BIT:IB • IT0005037905

Current stock price

11.7 EUR
-0.1 (-0.85%)
Last:

This IB.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. IB.MI Profitability Analysis

1.1 Basic Checks

  • In the past year IB was profitable.
  • IB had a positive operating cash flow in the past year.
  • IB had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years IB had a positive operating cash flow.
IB.MI Yearly Net Income VS EBIT VS OCF VS FCFIB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

1.2 Ratios

  • The Return On Assets of IB (1.16%) is comparable to the rest of the industry.
  • IB has a Return On Equity of 3.21%. This is comparable to the rest of the industry: IB outperforms 52.38% of its industry peers.
  • IB's Return On Invested Capital of 2.72% is in line compared to the rest of the industry. IB outperforms 57.14% of its industry peers.
Industry RankSector Rank
ROA 1.16%
ROE 3.21%
ROIC 2.72%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IB.MI Yearly ROA, ROE, ROICIB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8

1.3 Margins

  • The Profit Margin of IB (10.71%) is better than 76.19% of its industry peers.
  • IB's Profit Margin has declined in the last couple of years.
  • IB has a better Operating Margin (28.35%) than 80.95% of its industry peers.
  • IB's Operating Margin has declined in the last couple of years.
  • IB has a better Gross Margin (78.76%) than 71.43% of its industry peers.
  • IB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28.35%
PM (TTM) 10.71%
GM 78.76%
OM growth 3Y16.69%
OM growth 5Y-14.86%
PM growth 3YN/A
PM growth 5Y-32.5%
GM growth 3Y-2.79%
GM growth 5Y-3.94%
IB.MI Yearly Profit, Operating, Gross MarginsIB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

2

2. IB.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IB is destroying value.
  • IB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IB.MI Yearly Shares OutstandingIB.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
IB.MI Yearly Total Debt VS Total AssetsIB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • IB has an Altman-Z score of 0.51. This is a bad value and indicates that IB is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.51, IB is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of IB is 12.28, which is on the high side as it means it would take IB, 12.28 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 12.28, IB is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
  • IB has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
  • IB's Debt to Equity ratio of 1.05 is in line compared to the rest of the industry. IB outperforms 47.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 12.28
Altman-Z 0.51
ROIC/WACC0.47
WACC5.75%
IB.MI Yearly LT Debt VS Equity VS FCFIB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • IB has a Current Ratio of 0.60. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IB has a worse Current ratio (0.60) than 90.48% of its industry peers.
  • IB has a Quick Ratio of 0.60. This is a bad value and indicates that IB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IB's Quick ratio of 0.56 is on the low side compared to the rest of the industry. IB is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.56
IB.MI Yearly Current Assets VS Current LiabilitesIB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. IB.MI Growth Analysis

3.1 Past

  • IB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.34%.
  • The earnings per share for IB have been decreasing by -27.74% on average. This is quite bad
  • IB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.42%.
  • IB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.66% yearly.
EPS 1Y (TTM)-23.34%
EPS 3YN/A
EPS 5Y-27.74%
EPS Q2Q%-63.45%
Revenue 1Y (TTM)-23.42%
Revenue growth 3Y13.27%
Revenue growth 5Y7.66%
Sales Q2Q%-21.18%

3.2 Future

  • IB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.37% yearly.
  • IB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.59% yearly.
EPS Next Y51.25%
EPS Next 2Y19.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.84%
Revenue Next 2Y3.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IB.MI Yearly Revenue VS EstimatesIB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
IB.MI Yearly EPS VS EstimatesIB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. IB.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • IB is valuated quite expensively with a Price/Earnings ratio of 26.00.
  • IB's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, IB is valued at the same level.
  • The Price/Forward Earnings ratio is 9.39, which indicates a very decent valuation of IB.
  • Based on the Price/Forward Earnings ratio, IB is valued cheaper than 85.71% of the companies in the same industry.
  • IB is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.62, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26
Fwd PE 9.39
IB.MI Price Earnings VS Forward Price EarningsIB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IB is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, IB is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA 9.89
IB.MI Per share dataIB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • IB's earnings are expected to grow with 19.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3YN/A

2

5. IB.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.68%, IB has a reasonable but not impressive dividend return.
  • In the last 3 months the price of IB has falen by -20.95%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 2.28, IB has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, IB has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.68%

5.2 History

  • The dividend of IB decreases each year by -1.14%.
Dividend Growth(5Y)-1.14%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • IB pays out 63.30% of its income as dividend. This is not a sustainable payout ratio.
DP63.3%
EPS Next 2Y19.37%
EPS Next 3YN/A
IB.MI Yearly Income VS Free CF VS DividendIB.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M -15M
IB.MI Dividend Payout.IB.MI Dividend Payout, showing the Payout Ratio.IB.MI Dividend Payout.PayoutRetained Earnings

IB.MI Fundamentals: All Metrics, Ratios and Statistics

INIZIATIVE BRESCIANE-INBRE S

BIT:IB (3/31/2026, 7:00:00 PM)

11.7

-0.1 (-0.85%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners4.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap62.59M
Revenue(TTM)22.10M
Net Income(TTM)2.37M
Analysts84.44
Price Target17.44 (49.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.68%
Yearly Dividend0.67
Dividend Growth(5Y)-1.14%
DP63.3%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26
Fwd PE 9.39
P/S 2.83
P/FCF 7.66
P/OCF 4.17
P/B 0.85
P/tB 2.22
EV/EBITDA 9.89
EPS(TTM)0.45
EY3.85%
EPS(NY)1.25
Fwd EY10.65%
FCF(TTM)1.53
FCFY13.06%
OCF(TTM)2.81
OCFY23.98%
SpS4.13
BVpS13.79
TBVpS5.28
PEG (NY)0.51
PEG (5Y)N/A
Graham Number11.8151 (0.98%)
Profitability
Industry RankSector Rank
ROA 1.16%
ROE 3.21%
ROCE 3.72%
ROIC 2.72%
ROICexc 2.82%
ROICexgc 3.91%
OM 28.35%
PM (TTM) 10.71%
GM 78.76%
FCFM 36.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.69%
OM growth 5Y-14.86%
PM growth 3YN/A
PM growth 5Y-32.5%
GM growth 3Y-2.79%
GM growth 5Y-3.94%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF 12.28
Debt/EBITDA 4.88
Cap/Depr 71.03%
Cap/Sales 30.93%
Interest Coverage 250
Cash Conversion 94.45%
Profit Quality 345.16%
Current Ratio 0.6
Quick Ratio 0.56
Altman-Z 0.51
F-Score4
WACC5.75%
ROIC/WACC0.47
Cap/Depr(3y)117.85%
Cap/Depr(5y)184.8%
Cap/Sales(3y)46.38%
Cap/Sales(5y)82.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.34%
EPS 3YN/A
EPS 5Y-27.74%
EPS Q2Q%-63.45%
EPS Next Y51.25%
EPS Next 2Y19.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.42%
Revenue growth 3Y13.27%
Revenue growth 5Y7.66%
Sales Q2Q%-21.18%
Revenue Next Year2.84%
Revenue Next 2Y3.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.54%
EBIT growth 3Y32.18%
EBIT growth 5Y-8.34%
EBIT Next Year144%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.55%
OCF growth 3Y40.55%
OCF growth 5Y14.38%

INIZIATIVE BRESCIANE-INBRE S / IB.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INIZIATIVE BRESCIANE-INBRE S?

ChartMill assigns a fundamental rating of 4 / 10 to IB.MI.


What is the valuation status of INIZIATIVE BRESCIANE-INBRE S (IB.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to INIZIATIVE BRESCIANE-INBRE S (IB.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for INIZIATIVE BRESCIANE-INBRE S?

INIZIATIVE BRESCIANE-INBRE S (IB.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of INIZIATIVE BRESCIANE-INBRE S (IB.MI) stock?

The Price/Earnings (PE) ratio for INIZIATIVE BRESCIANE-INBRE S (IB.MI) is 26 and the Price/Book (PB) ratio is 0.85.


Is the dividend of INIZIATIVE BRESCIANE-INBRE S sustainable?

The dividend rating of INIZIATIVE BRESCIANE-INBRE S (IB.MI) is 6 / 10 and the dividend payout ratio is 63.3%.